Pharmaceuticals, Biotechnology and Life Sciences
Don't spend too much on your repeated translations.
Cut costs with Vikler Media. Visit: media.vikler.net
Secarna to collaborate with Scenic to develop first-in-class disease-modifying oligonucleotide therapies for severe genetic diseases.
Bristol Myers Squibb and Bain Capital announced Monday the creation of a new independent biopharmaceutical company, called NewCo, which will be focused on developing new therapies for autoimmune diseases that...
Micrima, a Bristol-based health tech company, is urging women to give themselves the gift of prioritising knowledge of their breast density this Christmas. Dense breast tissue is a relatively unknown but common breast cancer risk factor, which additionally makes it...
Brenntag, the global market leader in chemicals and ingredients distribution, held a celebration to mark its 150-year anniversary yesterday in...
Over-65s across the UK are set to benefit from potentially life-changing new treatment options for conditions like cancer and cardiovascular...
This Important Milestone Represents the Initiation of the Final Development Phase Before Commercial Approval LOWELL, Mass.–(BUSINESS WIRE)–#BoneRepair–RevBio, Inc., announced that…
PRINCETON, N.J.–(BUSINESS WIRE)–Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, announced today…
TURIN, Italy–(BUSINESS WIRE)–Reply [EXM, STAR: REY] today announced the start of a collaboration with the Department of Pathophysiology and Transplantation…
Delivering Deeper Patient Insights for Better Clinical Trials RALEIGH, N.C.–(BUSINESS WIRE)–Univo IRB today announced a partnership with The Patient View…
CancerVision provides tumor genomic profiling, while MRDVision enables ultra-sensitive monitoring of treatment response throughout dose escalation SAN DIEGO–(BUSINESS WIRE)–Inocras, a…
New investors include T. Rowe Price Investment Management, Inc., Baillie Gifford, Duquesne Family Office, Intuitive Ventures, EDBI, and Gates Frontier…
Life Sciences Industry Veteran Joins Convergent to Drive Strategic Growth as the Company Works to Advance its Lead Clinical Program…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies…
Expanded leadership reflects how AI is transforming both cell therapy manufacturing and the regulatory frameworks that govern it CAMBRIDGE, Mass.–(BUSINESS…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to…
